Monogenic diabetes – Basic Information

Go back

Monogenic diabetes is a rare group of diabetes forms caused by a change in just one gene, unlike the more common types 1 and 2 diabetes which involve many genes and other factors. Though uncommon, affecting only about 1 to 5 percent of people with diabetes, monogenic diabetes often appears in young people and is frequently misdiagnosed. Understanding this condition can open doors to more precise treatment and better health outcomes for affected individuals and their families.

How Common Is Monogenic Diabetes?

Monogenic diabetes is considered a rare form of diabetes. Research suggests that it accounts for approximately 1 to 5 percent of all diabetes cases diagnosed around the world.[1][2][5] Some estimates suggest that among people diagnosed with diabetes before the age of 30, monogenic diabetes may represent about 1 to 3 percent of these early-onset cases.[10]

The most common form of monogenic diabetes is called maturity-onset diabetes of the young, or MODY. This form alone may account for about 1 percent of all people living with diabetes.[3] Within the MODY group, certain genetic changes are more common than others. Mutations in the genes called HNF1A and GCK are responsible for the majority of MODY cases, with HNF1A affecting about 50 to 60 percent of those with monogenic diabetes, and GCK accounting for about 15 to 30 percent.[2][12]

Another form of monogenic diabetes, called neonatal diabetes mellitus, is even rarer. It occurs in newborns and very young infants. The prevalence of neonatal diabetes is estimated to be somewhere between 1 in 90,000 and 1 in 250,000 live births.[10] Babies who develop diabetes within their first six months of life almost always have a form of neonatal diabetes, and research shows that about 80 percent of those diagnosed before six months of age have a single gene cause.[1][3]

⚠️ Important
Many people with monogenic diabetes are misdiagnosed with either type 1 or type 2 diabetes. Up to 80 percent of monogenic diabetes cases may be misdiagnosed, which means many individuals might not be receiving the most appropriate treatment for their specific condition. If you or a family member has diabetes diagnosed at a young age, particularly with a strong family history of diabetes across multiple generations, it may be worth discussing genetic testing with your healthcare provider.

Because monogenic diabetes is relatively rare and shares symptoms with the more common forms of diabetes, many healthcare professionals may not immediately consider it as a diagnosis. This can lead to delays in accurate diagnosis and appropriate treatment. As awareness grows and genetic testing becomes more accessible, more people are being correctly identified with monogenic forms of diabetes, which allows them to receive tailored treatment approaches that can significantly improve their quality of life.[8]

What Causes Monogenic Diabetes?

Unlike type 1 and type 2 diabetes, which result from the interaction of many genes along with environmental factors like diet and lifestyle, monogenic diabetes is caused by a change, or mutation, in just one single gene.[2][12] These genes carry instructions for making proteins that are essential for the development, function, and regulation of the cells in the pancreas that produce insulin. When one of these genes has a mutation, the protein it produces may not work properly, which affects the body’s ability to produce or regulate insulin correctly.

Researchers have identified more than 20 different genes that can cause monogenic diabetes when they are mutated.[1][3] Each gene plays a specific role in how the body handles blood glucose. Some genes are involved in sensing glucose levels in the blood, while others control how much insulin is released from the pancreas, or how insulin-producing cells develop and survive over time.

The way monogenic diabetes is passed down through families is usually described as autosomal dominant. This means that if one parent carries the mutated gene, there is a 50 percent chance that each of their children will inherit the mutation and develop diabetes.[3][7] In some cases, however, the mutation can occur spontaneously in a child whose parents do not have the mutation. These are called de novo mutations, and they can then be passed on to future generations.[3]

Because monogenic diabetes is inherited, it often runs strongly in families across multiple generations. If you have a parent or grandparent with diabetes diagnosed at a young age, particularly before age 30, and several family members in different generations have diabetes, this pattern suggests that genetic testing might be helpful. Knowing your family history can be an important clue for healthcare providers trying to determine whether monogenic diabetes might be the cause of your symptoms.[7][16]

Who Is More Likely to Have Monogenic Diabetes?

Monogenic diabetes is most commonly diagnosed in children, teenagers, and young adults, though the exact age depends on the specific gene involved. For example, neonatal diabetes mellitus typically appears within the first six to twelve months of life.[1][11] On the other hand, MODY is usually diagnosed in adolescence or early adulthood, often before the age of 25 or 30.[2][7]

Individuals with a strong family history of diabetes are at higher risk for monogenic diabetes. If diabetes runs through multiple generations of your family, particularly if many relatives were diagnosed at a young age, this pattern increases the likelihood that the diabetes is caused by a single gene mutation rather than the combination of factors that lead to type 1 or type 2 diabetes.[16]

People who do not have obesity and who do not show typical features of type 1 or type 2 diabetes are also more likely to have monogenic diabetes. For instance, individuals with type 1 diabetes usually test positive for certain antibodies that attack the cells in the pancreas, but people with monogenic diabetes typically do not have these antibodies.[7][16] Similarly, type 2 diabetes is often associated with obesity and other metabolic conditions, but many forms of monogenic diabetes occur in individuals who are not overweight.

Another clue is the presence of detectable levels of a substance called C-peptide in the blood several years after diagnosis. C-peptide is a marker that shows the pancreas is still producing some insulin. In type 1 diabetes, C-peptide levels typically become very low or disappear after a few years, but in many forms of monogenic diabetes, C-peptide remains detectable, indicating that the pancreas continues to produce at least some insulin.[10][16]

Certain ethnic and geographic populations may also have higher rates of specific monogenic diabetes subtypes, though overall the condition is found across all populations worldwide. Genetic testing has become more accessible in recent years, which has helped identify more cases of monogenic diabetes that were previously misdiagnosed as type 1 or type 2 diabetes.[8]

What Are the Symptoms of Monogenic Diabetes?

The symptoms of monogenic diabetes are similar to those of other types of diabetes, which is one reason it is often misdiagnosed. Common symptoms include feeling very thirsty, needing to urinate frequently, losing weight without trying, feeling unusually tired, and having blurred vision.[9][21] These symptoms occur because the body is not managing blood glucose properly.

The specific symptoms and their severity can vary widely depending on which gene is affected and the type of mutation. Some people with certain forms of monogenic diabetes, particularly those with mutations in the GCK gene, may have only mildly elevated blood sugar levels that remain stable throughout their lives. These individuals may not experience noticeable symptoms at all and may only be diagnosed during routine blood tests or screening.[1][7]

In contrast, other forms of monogenic diabetes cause more significant and progressive increases in blood glucose. People with mutations in the HNF1A or HNF4A genes, for example, often develop more pronounced symptoms over time and require treatment to manage their blood sugar levels effectively.[1][7]

Babies with neonatal diabetes may show signs such as poor growth, dehydration, frequent urination, and irritability. In severe cases, they may develop a life-threatening condition called diabetic ketoacidosis, where the body begins to break down fat for energy because it cannot use glucose properly, leading to a buildup of harmful acids in the blood.[1]

Some forms of monogenic diabetes are associated with additional health problems beyond blood sugar control. For example, certain mutations can cause kidney abnormalities, such as cysts or underdeveloped kidneys, digestive problems, hearing loss, or learning difficulties.[6][7] These extra features can be important clues that help healthcare providers suspect monogenic diabetes rather than the more common forms.

Because the symptoms can be mild or mistaken for other conditions, many people with monogenic diabetes go undiagnosed or are misdiagnosed for years. This is why genetic testing is so important when the clinical picture suggests monogenic diabetes.[5]

How Can Monogenic Diabetes Be Prevented?

Because monogenic diabetes is caused by inherited genetic mutations, it cannot be prevented through lifestyle changes such as diet, exercise, or weight management. Unlike type 2 diabetes, where modifying risk factors like obesity and physical inactivity can significantly reduce the chance of developing the disease, monogenic diabetes occurs because of a genetic change that is present from birth or very early in life.[18]

If you have a family history of monogenic diabetes, or if genetic testing has identified that you carry a mutation associated with the condition, there is currently no way to prevent the diabetes from developing if the gene mutation is present. However, knowing that you or your family members carry the mutation can be very valuable. It allows for earlier diagnosis, more appropriate treatment, and better monitoring of blood sugar levels to prevent complications.

For individuals who know they carry a gene mutation but have not yet developed diabetes, regular monitoring of blood glucose levels may help detect changes early. In some forms of monogenic diabetes, such as those caused by the GCK gene mutation, blood sugar levels may be only mildly elevated and remain stable, so treatment may not be necessary. In these cases, simply being aware of the condition and monitoring it over time is often sufficient.[7][16]

If you have monogenic diabetes or carry a mutation, genetic counseling can be helpful. A genetic counselor can explain how the condition is inherited, the likelihood of passing it on to your children, and what steps can be taken to manage the condition if it develops. This information can help families make informed decisions about family planning and healthcare.[1]

While prevention of the genetic condition itself is not possible, preventing complications from poorly controlled blood sugar is achievable. Maintaining blood glucose levels within a healthy range through appropriate treatment, regular monitoring, and follow-up with healthcare providers can help prevent or delay serious complications such as damage to the eyes, kidneys, nerves, and heart.[1][11]

How Does Monogenic Diabetes Affect the Body?

Understanding how monogenic diabetes affects the body requires looking at how genes control the normal function of the pancreas and insulin production. The pancreas is an organ that produces insulin, a hormone that helps move glucose from the bloodstream into the body’s cells, where it is used for energy. When monogenic diabetes occurs, a mutation in a single gene disrupts this process.

The genes involved in monogenic diabetes typically affect the beta cells in the pancreas. Beta cells are specialized cells that sense blood glucose levels and release the right amount of insulin in response. When these genes are mutated, beta cells may not develop properly, may not sense glucose correctly, or may not release enough insulin.[2][12]

For example, mutations in the GCK gene affect a protein called glucokinase, which acts as a glucose sensor in beta cells. When this sensor is not working correctly, the beta cells do not recognize that blood glucose is elevated, so they do not release enough insulin. This results in mildly elevated blood sugar that remains fairly stable over time.[7]

Mutations in the HNF1A and HNF4A genes affect proteins that regulate how beta cells function and how much insulin they produce. When these proteins are faulty, beta cells gradually lose their ability to produce sufficient insulin, leading to progressively higher blood glucose levels over time.[7][16]

In neonatal diabetes, mutations in genes such as KCNJ11 and ABCC8 affect channels in the beta cell membrane that control insulin release. When these channels do not work properly, insulin cannot be released even when blood glucose levels are high, leading to very high blood sugar in newborns.[7]

The body’s inability to properly manage blood glucose leads to a cascade of effects. High blood sugar over time can damage blood vessels and nerves throughout the body. Small blood vessels in the eyes, kidneys, and nerves are particularly vulnerable. This can lead to vision problems, kidney disease, nerve damage that causes pain or numbness, and an increased risk of heart disease.[1][11]

Some forms of monogenic diabetes also affect organs beyond the pancreas. For instance, mutations in the HNF1B gene can cause kidney cysts, underdeveloped kidneys, and problems with other organs during development.[7] Mutations in other genes can lead to additional features such as learning difficulties, liver problems, or heart abnormalities.[3]

The severity of these effects depends on the specific gene involved and the nature of the mutation. Some people with monogenic diabetes have very mild disease that requires little or no treatment, while others have more severe disease that requires careful management to prevent complications.[1][8]

Ongoing Clinical Trials on Monogenic diabetes

  • Increasing the dose of glimepiride for patients with HNF1A-MODY or HNF4A-MODY diabetes

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark
  • Study on the Effects of Empagliflozin on Blood Sugar Levels in Patients with HNF1A-MODY Diabetes

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

References

https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/monogenic-neonatal-mellitus-mody

https://www.endocrine.org/patient-engagement/endocrine-library/monogenic-diabetes

https://monogenicdiabetes.uchicago.edu/what-monogenic-diabetes

https://beyondtype1.org/what-is-monogenic-diabetes/

https://www.jci.org/articles/view/142244

https://www.chop.edu/services/monogenic-and-atypical-diabetes-program

https://www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/monogenic-diabetes/

https://www.nature.com/articles/s41572-023-00421-w

https://www.uhhospitals.org/services/endocrinology-services/conditions-and-treatments/diabetes/conditions-and-treatments/monogenic-diabetes-genetic-diabetes

https://www.ncbi.nlm.nih.gov/books/NBK563964/

https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/monogenic-neonatal-mellitus-mody

https://www.endocrine.org/patient-engagement/endocrine-library/monogenic-diabetes

https://www.chop.edu/services/monogenic-and-atypical-diabetes-program

https://www.nature.com/articles/s43856-024-00556-1

https://www.jci.org/articles/view/142244

https://www.aafp.org/pubs/afp/issues/2022/0200/p162.html

https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/monogenic-neonatal-mellitus-mody

https://www.diabetes.org.uk/living-with-diabetes/your-stories/steph-nathan-mody

https://www.endocrine.org/patient-engagement/endocrine-library/monogenic-diabetes

https://diabetes.org/living-with-diabetes

https://my.clevelandclinic.org/health/diseases/mody-diabetes

https://www.byramhealthcare.com/blogs/everything-you-need-to-know-about-monogenic-diabetes

https://www.uchicagomedicine.org/forefront/pediatrics-articles/2023/december/hnf1a-mody-diabetes-patient-story

FAQ

How is monogenic diabetes different from type 1 and type 2 diabetes?

Monogenic diabetes is caused by a mutation in a single gene, whereas type 1 and type 2 diabetes result from many genes interacting with environmental factors. People with monogenic diabetes typically do not have the autoantibodies found in type 1 diabetes, and they often continue to produce some insulin even years after diagnosis. Unlike type 2 diabetes, monogenic diabetes is usually not associated with obesity or lifestyle factors.

Can monogenic diabetes be cured?

There is no cure for monogenic diabetes because it is caused by a permanent genetic mutation. However, certain forms can be very effectively managed with the right treatment. Some types require only diet and lifestyle management, others respond very well to oral medications, and some require insulin. The good news is that identifying the specific genetic cause allows for more precise and effective treatment approaches.

Should I get genetic testing if diabetes runs in my family?

Genetic testing may be helpful if you have diabetes diagnosed before age 30, a strong family history of diabetes across multiple generations, preserved insulin production (detectable C-peptide) years after diagnosis, no diabetes-related autoantibodies, and no obesity or other features of type 2 diabetes. Your healthcare provider can help determine whether genetic testing is appropriate for you based on your specific situation.

Will my children inherit monogenic diabetes if I have it?

Most forms of monogenic diabetes follow an autosomal dominant inheritance pattern, which means that each of your children has a 50 percent chance of inheriting the genetic mutation. However, not everyone who inherits the mutation will develop diabetes at the same age or with the same severity. Genetic counseling can help you understand the specific risks based on your type of monogenic diabetes.

What is the most common type of monogenic diabetes?

The most common form of monogenic diabetes is MODY caused by mutations in the HNF1A gene, which accounts for about 50 to 60 percent of monogenic diabetes cases. The second most common is caused by mutations in the GCK gene, accounting for about 15 to 30 percent of cases. Together, these two gene mutations are responsible for the majority of monogenic diabetes diagnoses.

🎯 Key takeaways

  • Monogenic diabetes is caused by a mutation in just one gene, unlike type 1 and type 2 diabetes which involve multiple genes and environmental factors.
  • It affects only 1 to 5 percent of all people with diabetes, making it a rare condition that is often misdiagnosed as type 1 or type 2 diabetes.
  • The two main forms are MODY, typically diagnosed in teens or young adults, and neonatal diabetes, which appears in the first year of life.
  • More than 20 different genes have been identified as causes of monogenic diabetes, with HNF1A and GCK being the most common.
  • A correct genetic diagnosis can dramatically change treatment, allowing some people to stop insulin injections and switch to oral medications or even no medication at all.
  • Monogenic diabetes often runs strongly in families across multiple generations, so a detailed family history is an important diagnostic clue.
  • People with certain types of monogenic diabetes may have only mildly elevated blood sugar that never causes symptoms or complications.
  • Genetic testing is recommended for those diagnosed before age 30 with a strong family history, no diabetes antibodies, and persistent insulin production years after diagnosis.